Monosomal karyotype in acute myeloid leukemia defines a distinct subgroup within the adverse cytogenetic risk category

Cancer Genetics

Volumn 206, Issue 1-2, 2013, Pages 32-36

  Voutiadou, Georgia ^a   Papaioannou, George ^a   Gaitatzi, Maria ^a   Lalayanni, Chrysavgi ^a   Syrigou, Antonia ^a   Vadikoliou, Chrysanthi ^a   Saloum, Riad ^a   Anagnostopoulos, Achilles ^a   Athanasiadou, Anastasia ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

AML; Cytogenetic risk; Monosomal karyotype; Prognosis

Indexed keywords

ANTHRACYCLINE; CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HUMAN CELL; INDUCTION CHEMOTHERAPY; KARYOTYPING; LEUKOCYTE COUNT; MAINTENANCE CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; MONOSOMY; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CYTOGENETICS; FEMALE; HUMANS; KARYOTYPE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MONOSOMY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84873466772     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.10.003     Document Type: Article

References (13)

1. WHO classification of tumours of the haematopoietic and lymphoid tissues 2008, International Agency for Research on Cancer (IARC), Lyon. S.H.C.C. Swerdlow, N.L. Harris (Eds.).
2. Grimwade D., Walker H., Oliver F., et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998, 92:2322-2333.
3. Slovak M.L., Kopecky K.J., Cassileth P.A., et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000, 96:4075-4083.
4. Byrd J.C., Mrózek K., Dodge R.K., et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002, 100:4325-4336.
5. Döhner H., Estey E.H., Amadori S., et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010, 115:453-474.
6. Breems D.A., Van Putten W.L., De Greef G.E., et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 2008, 26:4791-4797.
7. Medeiros B.C., Othus M., Fang M., et al. Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience. Blood 2010, 116:2224-2228.
8. Oran B., Dolan M., Cao Q., et al. Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia. Biol Blood Marrow Transplant 2011, 17:356-364.
9. Perrot A., Luquet I., Pigneux A., et al. Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities. Blood 2011, 118:679-685.
10. Fang M., Storer B., Estey E., et al. Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation. Blood 2011, 118:1490-1494.
11. Kayser S., Zucknick M., Döhner K., et al. Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies. Blood 2012, 119:551-558.
12. Shaffer L., Slovak M., Campbell L. ISCN: An International System for Human Cytogenetic Nomenclature 2009, Karger, Basel.
13. Nazha A., Bhatt V., Nogueras-Gonzalez G., et al. Prognostic Implication of Chromosome 17 Abnormalities in the Context of Monosomal Karyotype (MK) in Patients with Acute Myeloid Leukemia (AML) and Complex Cytogenetics. Blood (ASH Annual Meeting Abstracts) Nov 2011, 118:1495.